Literature DB >> 26352878

Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.

Ze-Tan Chen1, Ling Li1, Ya Guo2, Song Qu1, Wei Zhao1, Hao Chen1, Fang Su1, Jun Yin1, Qi-Yan Mo1, Xiao-Dong Zhu1.   

Abstract

Radioresistance is the major cause of poor prognosis in nasopharyngeal carcinoma (NPC). To identify and characterize the secretome associated with NPC radioresistance, we compared the conditioned serum-free medium of radioresistant CNE-2R cells with that of the parental radiosensitive CNE-2 cells using isobaric tags for relative and absolute quantitation (iTRAQ) with liquid chromatography-electrospray tandem mass spectrometry (LC-ESI-MS/MS) quantitative proteomics. Before proceeding to quantitative proteomics, we investigated the survival curves of CNE-2R and CNE-2 cells by colony formation assay, and the CNE-2R survival curves were significantly higher than those for CNE-2. In total, 3,581 proteins were identified in the quantitative proteomics experiments, and 40 proteins exhibited significant differences between the CNE-2R and CNE-2 cells. Twenty-six of the 40 proteins were secreted by classical, non-classical, or exosomal secretion pathways. To verify the reliability of iTRAQ quantitative proteomics, we applied western blotting (WB) to study the secretory protein expression of fibrillin-2, CD166, sulfhydryl oxidase 1 and cofilin-2, which are involved in cell adhesion, migration and invasion. The WB results showed that fibrillin-2 (p=0.017) and sulfhydryl oxidase 1 (p=0.000) were highly expressed in the CNE-2 cells, while CD166 (p=0.012) and cofilin-2 (p=0.003) were highly expressed in the CNE-2R cells, which was in accordance with iTRAQ quantitative proteomics. Finally, a phenotypic subset of CD166-positive NPC cells was verified by immunocytochemistry. In summary, we defined a collection of secretory proteins that may be relevant to the radioresistance in NPC cells, and we determined that CD166, which is widely used as a positive marker of cancer stem cells, is expressed in NPC cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26352878     DOI: 10.3892/or.2015.4255

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.

Authors:  Lei Zhou; Hong-Min Chen; Song Qu; Ling Li; Wei Zhao; Zhong-Guo Liang; Bin-Bin Yu; Kai-Hua Chen; Qi-Teng Lu; Guo-Xiang Lin; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-12-14

2.  Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.

Authors:  Bin-Bin Yu; Guo-Xiang Lin; Ling Li; Song Qu; Zhong-Guo Liang; Kai-Hua Chen; Lei Zhou; Qi-Teng Lu; Yong-Chu Sun; Xiao-Dong Zhu
Journal:  Med Sci Monit       Date:  2018-04-17

3.  SERPINB2 overexpression inhibited cell proliferation, invasion and migration, led to G2/M arrest, and increased radiosensitivity in nasopharyngeal carcinoma cells.

Authors:  Xiao-Mei Zhang; Tao Wang; Peng Hu; Bo Li; Hong Liu; Yu-Feng Cheng
Journal:  J Radiat Res       Date:  2019-05-01       Impact factor: 2.438

Review 4.  Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers.

Authors:  Hui Luo; Hong Ge
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

5.  Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

Authors:  Huan Lin; Ze-Tan Chen; Xiao-Dong Zhu; Ling Li; Song Qu; Zhao Wei; Fang Su; Jing-Ni Wei; Zhong-Guo Liang; Qi-Yan Mo; Jiang-Bo Wu; Hui-Ling Meng
Journal:  Oncotarget       Date:  2017-03-21

Review 6.  The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application.

Authors:  Huidan Luo; Bin Yi
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.